What Oncosimis Biotech does
Founded in 2016, Oncosimis Biotech operates in Health Tech offering the development and production of biosimilars at affordable costs. The company focuses on meeting the global demand for biosimilar drugs, particularly monoclonal antibodies and recombinant proteins, recognised for their safety and targeted efficacy. Its research and development strategy emphasises advanced process development methodologies aimed at addressing various medical conditions with unmet needs. As an Indian company, Oncosimis leverages lower facility and development costs to provide bio-pharmacotherapy to a significant number of domestic patients.
Who runs it
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Oncosimis Biotech yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.